GNPX
Price
$0.23
Change
-$0.02 (-8.00%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
6.56M
REVB
Price
$0.83
Change
-$0.04 (-4.60%)
Updated
Jun 25, 04:57 PM (EDT)
Capitalization
3.86M
Interact to see
Advertisement

GNPX vs REVB

Header iconGNPX vs REVB Comparison
Open Charts GNPX vs REVBBanner chart's image
Genprex
Price$0.23
Change-$0.02 (-8.00%)
Volume$27.2K
Capitalization6.56M
Revelation Biosciences
Price$0.83
Change-$0.04 (-4.60%)
Volume$400
Capitalization3.86M
GNPX vs REVB Comparison Chart in %
Loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNPX vs. REVB commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Buy and REVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GNPX: $0.25 vs. REVB: $0.87)
Brand notoriety: GNPX and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 176% vs. REVB: 39%
Market capitalization -- GNPX: $6.56M vs. REVB: $3.86M
GNPX [@Biotechnology] is valued at $6.56M. REVB’s [@Biotechnology] market capitalization is $3.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 1 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 1 green, 4 red.
According to our system of comparison, REVB is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 6 bullish TA indicator(s).

  • GNPX’s TA Score: 4 bullish, 4 bearish.
  • REVB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, REVB is a better buy in the short-term than GNPX.

Price Growth

GNPX (@Biotechnology) experienced а -16.67% price change this week, while REVB (@Biotechnology) price change was +10.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

GNPX is expected to report earnings on Apr 01, 2025.

REVB is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNPX($6.56M) has a higher market cap than REVB($3.86M). GNPX YTD gains are higher at: -70.643 vs. REVB (-88.205). REVB has higher annual earnings (EBITDA): -8.14M vs. GNPX (-19.14M). REVB has more cash in the bank: 3.71M vs. GNPX (3.47M). REVB has less debt than GNPX: REVB (0) vs GNPX (279K). GNPX (0) and REVB (0) have equivalent revenues.
GNPXREVBGNPX / REVB
Capitalization6.56M3.86M170%
EBITDA-19.14M-8.14M235%
Gain YTD-70.643-88.20580%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.47M3.71M94%
Total Debt279K0-
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXREVB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPW4.500.06
+1.35%
Medical Properties Trust
VTRS8.950.10
+1.13%
Viatris
APM0.97N/A
-0.01%
Aptorum Group Limited
BFIN11.50-0.02
-0.17%
BankFinancial Corp
ABUS3.37-0.04
-1.17%
Arbutus Biopharma Corp

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+9.17%
REVB - GNPX
48%
Loosely correlated
+12.40%
HOWL - GNPX
37%
Loosely correlated
N/A
AXON - GNPX
30%
Poorly correlated
+1.41%
TYRA - GNPX
30%
Poorly correlated
+0.31%
APVO - GNPX
30%
Poorly correlated
+6.46%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+12.40%
GNPX - REVB
48%
Loosely correlated
+9.17%
TCRT - REVB
46%
Loosely correlated
+9.60%
OGEN - REVB
36%
Loosely correlated
+1.40%
IMUX - REVB
33%
Poorly correlated
N/A
NTLA - REVB
32%
Poorly correlated
+3.68%
More